Concepedia

Caroline Sychterz

CS

Statistics

Publications

8

Citations

317

H-Index

8

Active since

2011

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

Bristol-Myers Squibb (United States)

Caroline Sychterz is an author at GlaxoSmithKline (United States) specializing in pharmacology, pharmacy, and pharmacokinetics.

ORCID

Publications per year

2011–2023

8

Publications

8

Bioavailability, metabolism and disposition of oral pazopanib in patients with advanced cancer

Yanli Deng, Caroline Sychterz, A. Benjamin Suttle et al. · Xenobiotica · 2012 · 86 citations

, , +16

Assessing a Novel Depot Delivery Strategy for Noninvasive Administration of VEGF/PDGF RTK Inhibitors for Ocular Neovascular Disease

Scott Robbie, Peter Lundh von Leithner, Meihua Ju et al. · Investigative Ophthalmology & Visual Science · 2013 · 75 citations

, , +17

Single ocular injection of a sustained-release anti -VEGF delivers 6 months pharmacokinetics and efficacy in a primate laser CNV model

Peter Adamson, Thomas Wilde, Eric Dobrzynski et al. · Journal of Controlled Release · 2016 · 59 citations · Full text

, , +17

Interrogating the relationship between rat in vivo tissue distribution and drug property data for >200 structurally unrelated molecules

Andrew W. Harrell, Caroline Sychterz, May Y. K. Ho et al. · Pharmacology Research & Perspectives · 2015 · 32 citations · Full text

, , +17

Antibody Subunit LC-MS Analysis for Pharmacokinetic and Biotransformation Determination from In-Life Studies for Complex Biotherapeutics

John F. Kellie, Kristen E. Pannullo, Yinghe Li et al. · Analytical Chemistry · 2020 · 22 citations

, , +17

1–5 of 8